Newly Diagnosed Multiple Myeloma Not Yet Recruiting Phase 2 Trials for Ixazomib (DB09570)

IndicationStatusPhase
DBCOND0036257 (Newly Diagnosed Multiple Myeloma)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03733691Phase 2 Maintenance Trial: Ixazomib Compared to Ixazomib-Lenalidomide Combination as Maintenance Therapy for Frontline Multiple Myeloma PatientsTreatment